Baidu
map
CURR PROTEIN PEPT SC 润色咨询

CURRENT PROTEIN & PEPTIDE SCIENCE

出版年份:2000 年文章数:1308 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:6.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:已中,要求合理,就是有点久。影响因子不高因为是非OA为主,少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:蛋白质<br>经验分享:编辑很专业效率也很高,每封邮件回复都很及时,另外润色费也是很便宜的,就是终审有点慢,还没收到完全接收的邮件,再等等,有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:投了一篇综述,2.10投稿,5.9一审结束,审稿人只提了几个小问题,送了润色,一周后修回,5.22收到临时接收的邮件。8.5和8.18两次proof,然后就online了,现在还没有见刊。总体来说偏慢,但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药学<br>经验分享:4月12号投稿,5月24号送审,中间修改过一次格式,现在结果未知,希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后,一直没消息,不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助,这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0<br>经验分享:这个杂志还是很不错的,杂志工作效率高,学术editor很认真、很负责,reviewer提了很多建设性修改意见,都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2023-09-12 ms3000001161611445 来自广东省

    审稿速度:24.0 | 投稿命中率:50.0
    经验分享:已中,要求合理,就是有点久。影响因子不高因为是非OA为主,少有的低分需要图片摘要进行说明的期刊。看好。

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:已中,要求合理,就是有点久。影响因子不高因为是非OA为主,少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:蛋白质<br>经验分享:编辑很专业效率也很高,每封邮件回复都很及时,另外润色费也是很便宜的,就是终审有点慢,还没收到完全接收的邮件,再等等,有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:投了一篇综述,2.10投稿,5.9一审结束,审稿人只提了几个小问题,送了润色,一周后修回,5.22收到临时接收的邮件。8.5和8.18两次proof,然后就online了,现在还没有见刊。总体来说偏慢,但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药学<br>经验分享:4月12号投稿,5月24号送审,中间修改过一次格式,现在结果未知,希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后,一直没消息,不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助,这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0<br>经验分享:这个杂志还是很不错的,杂志工作效率高,学术editor很认真、很负责,reviewer提了很多建设性修改意见,都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2022-06-28 ms5000000359930993

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:蛋白质
    经验分享:编辑很专业效率也很高,每封邮件回复都很及时,另外润色费也是很便宜的,就是终审有点慢,还没收到完全接收的邮件,再等等,有消息就更新

    15

    展开15条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:已中,要求合理,就是有点久。影响因子不高因为是非OA为主,少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:蛋白质<br>经验分享:编辑很专业效率也很高,每封邮件回复都很及时,另外润色费也是很便宜的,就是终审有点慢,还没收到完全接收的邮件,再等等,有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:投了一篇综述,2.10投稿,5.9一审结束,审稿人只提了几个小问题,送了润色,一周后修回,5.22收到临时接收的邮件。8.5和8.18两次proof,然后就online了,现在还没有见刊。总体来说偏慢,但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药学<br>经验分享:4月12号投稿,5月24号送审,中间修改过一次格式,现在结果未知,希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后,一直没消息,不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助,这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0<br>经验分享:这个杂志还是很不错的,杂志工作效率高,学术editor很认真、很负责,reviewer提了很多建设性修改意见,都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2022-10-03 ms5000001856769052

    审稿速度:3.0 | 投稿命中率:75.0
    经验分享:投了一篇综述,2.10投稿,5.9一审结束,审稿人只提了几个小问题,送了润色,一周后修回,5.22收到临时接收的邮件。8.5和8.18两次proof,然后就online了,现在还没有见刊。总体来说偏慢,但是比较容易中。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:已中,要求合理,就是有点久。影响因子不高因为是非OA为主,少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:蛋白质<br>经验分享:编辑很专业效率也很高,每封邮件回复都很及时,另外润色费也是很便宜的,就是终审有点慢,还没收到完全接收的邮件,再等等,有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:投了一篇综述,2.10投稿,5.9一审结束,审稿人只提了几个小问题,送了润色,一周后修回,5.22收到临时接收的邮件。8.5和8.18两次proof,然后就online了,现在还没有见刊。总体来说偏慢,但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药学<br>经验分享:4月12号投稿,5月24号送审,中间修改过一次格式,现在结果未知,希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后,一直没消息,不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助,这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0<br>经验分享:这个杂志还是很不错的,杂志工作效率高,学术editor很认真、很负责,reviewer提了很多建设性修改意见,都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2022-05-25 120cd24bm30(暂无昵称)

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:药学
    经验分享:4月12号投稿,5月24号送审,中间修改过一次格式,现在结果未知,希望能中

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:已中,要求合理,就是有点久。影响因子不高因为是非OA为主,少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:蛋白质<br>经验分享:编辑很专业效率也很高,每封邮件回复都很及时,另外润色费也是很便宜的,就是终审有点慢,还没收到完全接收的邮件,再等等,有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:投了一篇综述,2.10投稿,5.9一审结束,审稿人只提了几个小问题,送了润色,一周后修回,5.22收到临时接收的邮件。8.5和8.18两次proof,然后就online了,现在还没有见刊。总体来说偏慢,但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药学<br>经验分享:4月12号投稿,5月24号送审,中间修改过一次格式,现在结果未知,希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后,一直没消息,不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助,这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0<br>经验分享:这个杂志还是很不错的,杂志工作效率高,学术editor很认真、很负责,reviewer提了很多建设性修改意见,都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2022-06-14 1225ebb0m52(暂无昵称)

    6月5号修回后,一直没消息,不知道还要等多久

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:已中,要求合理,就是有点久。影响因子不高因为是非OA为主,少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:蛋白质<br>经验分享:编辑很专业效率也很高,每封邮件回复都很及时,另外润色费也是很便宜的,就是终审有点慢,还没收到完全接收的邮件,再等等,有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:投了一篇综述,2.10投稿,5.9一审结束,审稿人只提了几个小问题,送了润色,一周后修回,5.22收到临时接收的邮件。8.5和8.18两次proof,然后就online了,现在还没有见刊。总体来说偏慢,但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药学<br>经验分享:4月12号投稿,5月24号送审,中间修改过一次格式,现在结果未知,希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后,一直没消息,不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助,这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0<br>经验分享:这个杂志还是很不错的,杂志工作效率高,学术editor很认真、很负责,reviewer提了很多建设性修改意见,都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2021-12-27 小动量

    回复评审的意见和期刊编辑的意见有什么不同?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:已中,要求合理,就是有点久。影响因子不高因为是非OA为主,少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:蛋白质<br>经验分享:编辑很专业效率也很高,每封邮件回复都很及时,另外润色费也是很便宜的,就是终审有点慢,还没收到完全接收的邮件,再等等,有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:投了一篇综述,2.10投稿,5.9一审结束,审稿人只提了几个小问题,送了润色,一周后修回,5.22收到临时接收的邮件。8.5和8.18两次proof,然后就online了,现在还没有见刊。总体来说偏慢,但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药学<br>经验分享:4月12号投稿,5月24号送审,中间修改过一次格式,现在结果未知,希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后,一直没消息,不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助,这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0<br>经验分享:这个杂志还是很不错的,杂志工作效率高,学术editor很认真、很负责,reviewer提了很多建设性修改意见,都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2021-12-27 Gym璨烨

    评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:已中,要求合理,就是有点久。影响因子不高因为是非OA为主,少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:蛋白质<br>经验分享:编辑很专业效率也很高,每封邮件回复都很及时,另外润色费也是很便宜的,就是终审有点慢,还没收到完全接收的邮件,再等等,有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:投了一篇综述,2.10投稿,5.9一审结束,审稿人只提了几个小问题,送了润色,一周后修回,5.22收到临时接收的邮件。8.5和8.18两次proof,然后就online了,现在还没有见刊。总体来说偏慢,但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药学<br>经验分享:4月12号投稿,5月24号送审,中间修改过一次格式,现在结果未知,希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后,一直没消息,不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助,这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0<br>经验分享:这个杂志还是很不错的,杂志工作效率高,学术editor很认真、很负责,reviewer提了很多建设性修改意见,都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2017-07-18 yang_liping1

    虽然今年没有什么大变化,以后再看看

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:已中,要求合理,就是有点久。影响因子不高因为是非OA为主,少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:蛋白质<br>经验分享:编辑很专业效率也很高,每封邮件回复都很及时,另外润色费也是很便宜的,就是终审有点慢,还没收到完全接收的邮件,再等等,有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:投了一篇综述,2.10投稿,5.9一审结束,审稿人只提了几个小问题,送了润色,一周后修回,5.22收到临时接收的邮件。8.5和8.18两次proof,然后就online了,现在还没有见刊。总体来说偏慢,但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药学<br>经验分享:4月12号投稿,5月24号送审,中间修改过一次格式,现在结果未知,希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后,一直没消息,不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助,这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0<br>经验分享:这个杂志还是很不错的,杂志工作效率高,学术editor很认真、很负责,reviewer提了很多建设性修改意见,都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2017-03-03 PeiPei..

    求助,这个期刊审稿时间一般是多久

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2157407, encodeId=928d215e40747, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:已中,要求合理,就是有点久。影响因子不高因为是非OA为主,少有的低分需要图片摘要进行说明的期刊。看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0775546096, createdName=ms3000001161611445, createdTime=Tue Sep 12 21:47:50 CST 2023, time=2023-09-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1229140, encodeId=522c1229140d6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:蛋白质<br>经验分享:编辑很专业效率也很高,每封邮件回复都很及时,另外润色费也是很便宜的,就是终审有点慢,还没收到完全接收的邮件,再等等,有消息就更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12b65702750, createdName=ms5000000359930993, createdTime=Tue Jun 28 13:21:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091567, encodeId=6684209156e8a, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:投了一篇综述,2.10投稿,5.9一审结束,审稿人只提了几个小问题,送了润色,一周后修回,5.22收到临时接收的邮件。8.5和8.18两次proof,然后就online了,现在还没有见刊。总体来说偏慢,但是比较容易中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Mon Oct 03 10:18:34 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222328, encodeId=b7fd1222328b2, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药学<br>经验分享:4月12号投稿,5月24号送审,中间修改过一次格式,现在结果未知,希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d11e2208303, createdName=120cd24bm30(暂无昵称), createdTime=Wed May 25 15:03:23 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226444, encodeId=76ff122644420, content=6月5号修回后,一直没消息,不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90d42326387, createdName=1225ebb0m52(暂无昵称), createdTime=Tue Jun 14 18:15:11 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099335, encodeId=3120109933569, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099336, encodeId=a7ea1099336bd, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540175, encodeId=01745401e5a9, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533685, encodeId=239c53368572, content=求助,这个期刊审稿时间一般是多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3122030018, createdName=PeiPei.., createdTime=Fri Mar 03 12:23:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832310, encodeId=089f832310d7, content=审稿速度:3.0<br>经验分享:这个杂志还是很不错的,杂志工作效率高,学术editor很认真、很负责,reviewer提了很多建设性修改意见,都很专业。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a25413959, createdName=ms4895215858607754, createdTime=Wed Jun 01 22:27:42 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2016-06-01 ms4895215858607754

    审稿速度:3.0
    经验分享:这个杂志还是很不错的,杂志工作效率高,学术editor很认真、很负责,reviewer提了很多建设性修改意见,都很专业。

    0

共39条页码: 1/4页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map